Functional Consequences of Repeated Organophosphate Exposure: Potential Non- Cholinergic Mechanisms Alvin V
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Severe Organophosphate Poisoning with Delayed Cholinergic Crisis, Intermediate Syndrome and Organophosphate Induced Delayed Polyneuropathy on Succession
Organophosphate Poisoning… Aklilu A 203 CASE REPORT SEVERE ORGANOPHOSPHATE POISONING WITH DELAYED CHOLINERGIC CRISIS, INTERMEDIATE SYNDROME AND ORGANOPHOSPHATE INDUCED DELAYED POLYNEUROPATHY ON SUCCESSION Aklilu Azazh ABSTRACT Organophosphate compounds are the organic derivatives of Phosphorous containing acids and their effect on neuromuscular junction and Autonomic Synapses is clinically important. After exposure these agents cause acute and sub acute manifestations depending on the type and severity of the agents like Acute Cholinergic Manifestations, Intermediate Syndrome with Nicotinic features and Delayed Central Nervous System Complications. The patient reported here had severe Organophosphate Poisoning with various rare complications on a succession. This is the first report of Organophosphates Poisoning complicated by Intermediate Syndrome and Organophosphate Induced Delayed Polyneuropathy in Ethiopia and it is reported to increase awareness of health care workers on these rare complications of a common problem. INTRODUCTION phosphorylated by the Phosphate end of Organophosphates; then the net result is Organophosphate compounds are the organic accumulation of excessive Acetyl Chlorine with derivatives of Phosphorous containing acids and resultant effect on Muscarinic, Nicotinic and their effect on Neuromuscular Junction and central nervous system (Figure 2). Autonomic synapses is clinically important. In the Neuromuscular Junction Acetylcholine is released Following classical OP poisoning, three well when a nerve impulse reaches -
Protocol for a Randomised Controlled Trial: Efficacy of Donepezil Against
BMJ Open: first published as 10.1136/bmjopen-2013-003533 on 25 September 2013. Downloaded from Open Access Protocol Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson’s disease (EDAP) Hideyuki Sawada, Tomoko Oeda To cite: Sawada H, Oeda T. ABSTRACT ARTICLE SUMMARY Protocol for a randomised Introduction: Psychosis, including hallucinations and controlled trial: efficacy of delusions, is one of the important non-motor problems donepezil against psychosis Strengths and limitations of this study in patients with Parkinson’s disease (PD) and is in Parkinson’s disease ▪ In previous randomised controlled trials for (EDAP). BMJ Open 2013;3: possibly associated with cholinergic neuronal psychosis the efficacy was investigated in patients e003533. doi:10.1136/ degeneration. The EDAP (Efficacy of Donepezil against who presented with psychosis and the primary bmjopen-2013-003533 Psychosis in PD) study will evaluate the efficacy of endpoint was improvement of psychotic symp- donepezil, a brain acetylcholine esterase inhibitor, for toms. By comparison, this study is designed to prevention of psychosis in PD. ▸ Prepublication history for evaluate the prophylactic effect in patients this paper is available online. Methods and analysis: Psychosis is assessed every without current psychosis. Because psychosis To view these files please 4 weeks using the Parkinson Psychosis Questionnaire may be overlooked and underestimated it is visit the journal online (PPQ) and patients with PD whose PPQ-B score assessed using a questionnaire, Parkinson (http://dx.doi.org/10.1136/ (hallucinations) and PPQ-C score (delusions) have Psychosis Questionnaire (PPQ) every 4 weeks. bmjopen-2013-003533). been zero for 8 weeks before enrolment are ▪ The strength of this study is its prospective randomised to two arms: patients receiving donepezil design using the preset definition of psychosis Received 3 July 2013 hydrochloride or patients receiving placebo. -
Supplementary Information
Supplementary Information Network-based Drug Repurposing for Novel Coronavirus 2019-nCoV Yadi Zhou1,#, Yuan Hou1,#, Jiayu Shen1, Yin Huang1, William Martin1, Feixiong Cheng1-3,* 1Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA 2Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA 3Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA #Equal contribution *Correspondence to: Feixiong Cheng, PhD Lerner Research Institute Cleveland Clinic Tel: +1-216-444-7654; Fax: +1-216-636-0009 Email: [email protected] Supplementary Table S1. Genome information of 15 coronaviruses used for phylogenetic analyses. Supplementary Table S2. Protein sequence identities across 5 protein regions in 15 coronaviruses. Supplementary Table S3. HCoV-associated host proteins with references. Supplementary Table S4. Repurposable drugs predicted by network-based approaches. Supplementary Table S5. Network proximity results for 2,938 drugs against pan-human coronavirus (CoV) and individual CoVs. Supplementary Table S6. Network-predicted drug combinations for all the drug pairs from the top 16 high-confidence repurposable drugs. 1 Supplementary Table S1. Genome information of 15 coronaviruses used for phylogenetic analyses. GenBank ID Coronavirus Identity % Host Location discovered MN908947 2019-nCoV[Wuhan-Hu-1] 100 Human China MN938384 2019-nCoV[HKU-SZ-002a] 99.99 Human China MN975262 -
Neurology of Acute Organophosphate Poisoning
Indian Perspective Neurology of acute organophosphate poisoning Gagandeep Singh, Dheeraj Khurana1 Departments of Neurology, Dayanand Medical College, Ludhiana, and 1Postgraduate Institute of Medical Education and Research, Chandigarh, India Abstract Acute organophosphate (OP) poisoning is one of the most common poisonings in emergency medicine and toxicological practice in some of the less-developed nations in South Asia. Traditionally, OP poisoning comes under the domain of emergency physicians, internists, intensivists, and toxicologists. However, some of the complications following OP poisoning are neurological and involve neurologists. The pathophysiological basis for the clinical manifestations of OP poisoning is inactivation of the enzyme, acetylcholinesterase at the peripheral nicotinic and muscarinic and central nervous system (CNS) nerve terminals and junctions. Nicotinic manifestations occur in severe cases and late in the course; these comprise of fasciculations and neuromuscular paralysis. There is a good correlation between the electrophysiological abnormalities and the severity of the clinical manifestations. Neurophysiological abnormalities characteristic of nicotinic junctions (mainly neuromuscular junction) dysfunction include: (1) single, supramaximal electrical-stimulus-induced repetitive response/s, (2) decrement–increment response to high frequency (30 Hz) repetitive nerve stimulation (RNS), and (3) decremental response to high frequency (30 Hz) RNS. Atropine ameliorates muscarinic manifestations. Therapeutic Address for correspondence: Dr. Gagandeep Singh, agents that can ameliorate nicotinic manifestations, mainly neuromuscular, are oximes. Department of Neurology, However, the evidence for this effect is inconclusive. This may be due to the fact that Dayanand Medical College, there are several factors that determine the therapeutic effect of oximes. These factors Ludhiana - 141 001, include: The OP compound responsible for poisoning, duration of poisoning, severity of Punjab, India. -
The Role of Serotonin in Memory: Interactions with Neurotransmitters and Downstream Signaling
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Bushehr University of Medical Sciences Repository Exp Brain Res (2014) 232:723–738 DOI 10.1007/s00221-013-3818-4 REVIEW The role of serotonin in memory: interactions with neurotransmitters and downstream signaling Mohammad Seyedabadi · Gohar Fakhfouri · Vahid Ramezani · Shahram Ejtemaei Mehr · Reza Rahimian Received: 28 April 2013 / Accepted: 20 December 2013 / Published online: 16 January 2014 © Springer-Verlag Berlin Heidelberg 2014 Abstract Serotonin, or 5-hydroxytryptamine (5-HT), is there has been an alteration in the density of serotonergic found to be involved in many physiological or pathophysi- receptors in aging and Alzheimer’s disease, and serotonin ological processes including cognitive function. Seven dis- modulators are found to alter the process of amyloidogen- tinct receptors (5-HT1–7), each with several subpopulations, esis and exert cognitive-enhancing properties. Here, we dis- have been identified for serotonin, which are different in cuss the serotonin-induced modulation of various systems terms of localization and downstream signaling. Because involved in mnesic function including cholinergic, dopa- of the development of selective agonists and antagonists minergic, GABAergic, glutamatergic transmissions as well for these receptors as well as transgenic animal models as amyloidogenesis and intracellular pathways. of cognitive disorders, our understanding of the role of serotonergic transmission in learning and memory has Keywords Serotonin · Memory · Signaling pathways improved in recent years. A large body of evidence indi- cates the interplay between serotonergic transmission and Abbreviations other neurotransmitters including acetylcholine, dopamine, 2PSDT Two-platform spatial discrimination task γ-aminobutyric acid (GABA) and glutamate, in the neu- 3xTg-AD Triple-transgenic mouse model of Alzheimer’s robiological control of learning and memory. -
Nerve Agent - Lntellipedia Page 1 Of9 Doc ID : 6637155 (U) Nerve Agent
This document is made available through the declassification efforts and research of John Greenewald, Jr., creator of: The Black Vault The Black Vault is the largest online Freedom of Information Act (FOIA) document clearinghouse in the world. The research efforts here are responsible for the declassification of MILLIONS of pages released by the U.S. Government & Military. Discover the Truth at: http://www.theblackvault.com Nerve Agent - lntellipedia Page 1 of9 Doc ID : 6637155 (U) Nerve Agent UNCLASSIFIED From lntellipedia Nerve Agents (also known as nerve gases, though these chemicals are liquid at room temperature) are a class of phosphorus-containing organic chemicals (organophosphates) that disrupt the mechanism by which nerves transfer messages to organs. The disruption is caused by blocking acetylcholinesterase, an enzyme that normally relaxes the activity of acetylcholine, a neurotransmitter. ...--------- --- -·---- - --- -·-- --- --- Contents • 1 Overview • 2 Biological Effects • 2.1 Mechanism of Action • 2.2 Antidotes • 3 Classes • 3.1 G-Series • 3.2 V-Series • 3.3 Novichok Agents • 3.4 Insecticides • 4 History • 4.1 The Discovery ofNerve Agents • 4.2 The Nazi Mass Production ofTabun • 4.3 Nerve Agents in Nazi Germany • 4.4 The Secret Gets Out • 4.5 Since World War II • 4.6 Ocean Disposal of Chemical Weapons • 5 Popular Culture • 6 References and External Links --------------- ----·-- - Overview As chemical weapons, they are classified as weapons of mass destruction by the United Nations according to UN Resolution 687, and their production and stockpiling was outlawed by the Chemical Weapons Convention of 1993; the Chemical Weapons Convention officially took effect on April 291997. Poisoning by a nerve agent leads to contraction of pupils, profuse salivation, convulsions, involuntary urination and defecation, and eventual death by asphyxiation as control is lost over respiratory muscles. -
3-27-2017 Nerve Agents
Week of March 13, 2017 – Nerve Agents Last month, on February 13, Kim Jong-nam, the exiled half-brother of North Korea's ruler, Kim Jong Un, was murdered by having the nerve agent, VX-gas, sprayed into his face while at Malaysia’s Kuala Lumpur International Airport. According to the Council on Foreign Relations (CFR), VX is the most toxic nerve agent ever synthesized. The CFR (founded in 1921) is a United States 4900-member organization, nonprofit, publisher, and think tank specializing in U.S. foreign policy and international affairs. The median lethal dose (LD50) of VX due to skin contact (not ingestion) for humans is estimated to be about 10 mg or 0.00035 ounces (that’s about 1/20 of a drop of liquid!). The median lethal airborne concentration (LC50) for this material, for which humans would inhale, is estimated to be 30 – 50 milligrams per cubic meter for only one minute! Typically, inhalation exposures are measured over an 8-hour time period. Yet, the effectiveness of VX is measured as an airborne exposure contaminant within a minute time period! VX is one a of number of chemical substances that is classified as a nerve agent. The principal nerve agents are sarin (GB), soman (GD), tabun (GA), and VX. They are manmade compounds that have been manufactured for the sole purpose to be used in chemical warfare. Nerve agents are organophosphorus compounds and therefore, are similar in mechanism of action as a number of pesticides; some of the most notable being malathion, parathion, and diazinon. As its name implies, these chemicals have a phosphorus atom connected to an organic molecule; the molecular variations of these materials are quite numerous. -
Chlorpyrifos (Dursban) Ddvp (Dichlorvos) Diazinon Malathion Parathion
CHLORPYRIFOS (DURSBAN) DDVP (DICHLORVOS) DIAZINON MALATHION PARATHION Method no.: 62 Matrix: Air Procedure: Samples are collected by drawing known volumes of air through specially constructed glass sampling tubes, each containing a glass fiber filter and two sections of XAD-2 adsorbent. Samples are desorbed with toluene and analyzed by GC using a flame photometric detector (FPD). Recommended air volume and sampling rate: 480 L at 1.0 L/min except for Malathion 60 L at 1.0 L/min for Malathion Target concentrations: 1.0 mg/m3 (0.111 ppm) for Dichlorvos (PEL) 0.1 mg/m3 (0.008 ppm) for Diazinon (TLV) 0.2 mg/m3 (0.014 ppm) for Chlorpyrifos (TLV) 15.0 mg/m3 (1.11 ppm) for Malathion (PEL) 0.1 mg/m3 (0.008 ppm) for Parathion (PEL) Reliable quantitation limits: 0.0019 mg/m3 (0.21 ppb) for Dichlorvos (based on the RAV) 0.0030 mg/m3 (0.24 ppb) for Diazinon 0.0033 mg/m3 (0.23 ppb) for Chlorpyrifos 0.0303 mg/m3 (2.2 ppb) for Malathion 0.0031 mg/m3 (0.26 ppb) for Parathion Standard errors of estimate at the target concentration: 5.3% for Dichlorvos (Section 4.6.) 5.3% for Diazinon 5.3% for Chlorpyrifos 5.6% for Malathion 5.3% for Parathion Status of method: Evaluated method. This method has been subjected to the established evaluation procedures of the Organic Methods Evaluation Branch. Date: October 1986 Chemist: Donald Burright Organic Methods Evaluation Branch OSHA Analytical Laboratory Salt Lake City, Utah 1 of 27 T-62-FV-01-8610-M 1. -
Hawaii on Two Foliage Plants, Dwarf Brassaia Diazinon Plant After Spots
in Japan and England will be given by Tosh Fu- {Brassaia arboricola) and Dwarf Ti {Cordyline chikami of O.M. Scotts and Ray McMicken of B. terminalis 'Madameandre') to determine their Hayman Co., respectively. phototoxicity to selected insecticides and acara- cides. Plants, growing in 6-inch pots, were treated Farwest Show by submerging the aerial portions of the plant in Farwest Nursery, Garden, and Supply Show water suspensions of 7 pesticides for 15seconds. will be September 8-10, 1975, at the Memorial Granular formulations of 2 pesticides were ap Coliseum in Portland, Oregon. For information plied to the soil surface. Materials, at 2X stand contact: Farwest Nursery Show, Suite GA-7, ard rates, were as follows: 222 S.W. Harrison, Protland, OR. 97201. Amount formulation per: ASHS The 72d annual meeting of ASHS (American Material and formulation 1-gallon water 6-inch pot Society for Horticultural Science) will be held in chlorobenzilate 4E 2t — Honolulu, September 8 to 13, 1975, at the dicofol (Kelthane) 35WP 2T - Sheraton-Waikiki Hotel. Meeting concurrently Pentac 50WP 2T — with ASHS will be the American Horticulture carbaryl (Sevin) 50WP 2T - Society. The University of Hawaii will host the diazinon AG500 (48% EC) 2t - meeting with Dr. Richard Bullock, general chair dimethoate (Cygon) 2E 2t — man. Dr. Henry Nakasone will serve as assistant Volck Oil Supreme 2T - general chairman, Dr. Phil Parvin as local arrange aldicarb (Temik) 10G - 1.5t ments chairman, and Dr. Richard Criley as pro disulfoton (Di-Syston) 15G - 1.5t gram chairman. Neighbor island tours will be untreated controls - conducted following the meetings. -
Role of Muscarinic Acetylcholine Receptors in Adult Neurogenesis and Cholinergic Seizures
Role of Muscarinic Acetylcholine Receptors in Adult Neurogenesis and Cholinergic Seizures Rebecca L. Kow A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2014 Reding Committee: Neil Nathanson, Chair Sandra Bajjalieh Joseph Beavo Program Authorized to Offer Degree: Pharmacology ©Copyright 2014 Rebecca L. Kow University of Washington Abstract Role of Muscarinic Acetylcholine Receptors in Adult Neurogenesis and Cholinergic Seizures Rebecca L. Kow Chair of the Supervisory Committee: Professor Neil M. Nathanson Department of Pharmacology Muscarinic acetylcholine receptors (mAChRs) are G protein-coupled receptors (GPCRs) that mediate important functions in the periphery and in the central nervous systems. In the brain these receptors modulate many processes including learning, locomotion, pain, and reward behaviors. In this work we investigated the role of mAChRs in adult neurogenesis and further clarified the regulation of muscarinic agonist-induced seizures. We first investigated the role of mAChRs in adult neurogenesis in the subventricular zone (SVZ) and the subgranular zone (SGZ). We were unable to detect any modulation of adult neurogenesis by mAChRs. Administration of muscarinic agonists or antagonists did not alter proliferation or viability of adult neural progenitor cells (aNPCs) in vitro. Similarly, muscarinic agonists did not alter proliferation or survival of new adult cells in vivo. Loss of the predominant mAChR subtype in the forebrain, the M1 receptor, also caused no alterations in adult neurogenesis in vitro or in vivo, indicating that the M1 receptor does not mediate the actions of endogenous acetylcholine on adult neurogenesis. We also investigated the interaction between mAChRs and cannabinoid receptor 1 (CB1) in muscarinic agonist pilocarpine-induced seizures. -
Drug Class Review Ophthalmic Cholinergic Agonists
Drug Class Review Ophthalmic Cholinergic Agonists 52:40.20 Miotics Acetylcholine (Miochol-E) Carbachol (Isopto Carbachol; Miostat) Pilocarpine (Isopto Carpine; Pilopine HS) Final Report November 2015 Review prepared by: Melissa Archer, PharmD, Clinical Pharmacist Carin Steinvoort, PharmD, Clinical Pharmacist Gary Oderda, PharmD, MPH, Professor University of Utah College of Pharmacy Copyright © 2015 by University of Utah College of Pharmacy Salt Lake City, Utah. All rights reserved. Table of Contents Executive Summary ......................................................................................................................... 3 Introduction .................................................................................................................................... 4 Table 1. Glaucoma Therapies ................................................................................................. 5 Table 2. Summary of Agents .................................................................................................. 6 Disease Overview ........................................................................................................................ 8 Table 3. Summary of Current Glaucoma Clinical Practice Guidelines ................................... 9 Pharmacology ............................................................................................................................... 10 Methods ....................................................................................................................................... -
Ambient Water Quality Criteria for Chlorpyrifos
United State. Office of Water EPA 440/5-86~05 Environmental Protection Regulations and Standards September 1986 Amy l. lea~erry Agency Criteria and Standards Division Washington DC 20460 Water &EPA Ambient Wat'er Quality Criteria for Chlorpyrifos - 1986 &~IENT AQUATIC LIFE WATER QUALITY CRITERIA FOR CHLORPYRIFOS U.S. ENVIRONMENTAL PROTECTION AGENCY OFFICE OF RESEARCH AND DEVELOPMENT ENVIRONMENTAL RESEARCH LABORATORIES DULUTH, MINNESOTA NARRAGANSETT, RHODE ISLAND NOTICES This document has been reviewed by the Criteria and Standards Division, Office of Water Regulations and Standards, U.S. Environmental Protection Agency, and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. This document is availaryle to the public throu~h the National Technical Inf0rmation Service (NTIS), 5285 Port Royal Road, Springfield, VA 22161. 11 FOREWORD Section 304(a)(1) of the Clean Water Act of 1977 (P.L. 95-217) requires the Administrator of the Environmental Protection Agency to publish water quality criteria that accurately reflect the latest scientific knowledge on the kind and extent of all identifiable effects on health and welfare that might be expected from the presence of pollutants in any body of water~ including ground water. This document is a revision of proposed criteria based upon consideration of comments received from other Federal agencies~ State agencies~ special interest groups~ and individual scientists. Criteria contained in this document replace any previously published EPA aquatic life criteria for the same pollutant(s). The term "water quality criteria" is used in two sections of the Clean Water Act~ section 304(a)(1) and section 303(c)(2).